Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co Portfolio 13F
Ronald Muhlenkamp Holdings Activity
- Portfolio value:
- $547.43M≈ (-$14M≈)
- Previous value:
- $561.75M≈
- # of changes:
- 56
- New positions:
- 10
- Reported for:
- 30 Sep 2014 (Q3)
- Latest filing date:
- 14 Nov 2014
Muhlenkamp & Co has disclosed a total of 56 changes to the portfolio in the (2014 Q3) SEC report(s): increased the number of shares of 26, bought 10 totally new, decreased the number of shares of 17 and completely sold out 3 position(s).
What stocks did Ronald Muhlenkamp buy in 2014 Q3?
During 2014 Q3 Ronald Muhlenkamp has bought 36 securities out of which top 5 purchases (by % change to portfolio) were (JPM) JPMorgan Chase & Co (added shares +0.66%), (GILD) Gilead Sciences Inc (added shares +42.59%), (ARRS-OLD) ARRIS GROUP INC (added shares +28.71%), (HAL) Halliburton Company (added shares +1.13%) and (CELG) Celgene Corp (added shares +1.94%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.